featured
Efficacy and Safety of Baricitinib in the Treatment of Adults With Alopecia Areata
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of the Oral Janus Kinase Inhibitor Baricitinib in the Treatment of Adults With Alopecia Areata: Phase 2 Results From a Randomized Controlled Study
J Am Acad Dermatol 2021 Jun 03;[EPub Ahead of Print], B King, J Ko, S Forman, M Ohyama, N Mesinkovska, G Yu, J McCollam, M Gamalo, J Janes, E Edson-Heredia, K Holzwarth, Y DutroncFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.